YIH
EOLS icon

Y-Intercept (HK)’s Evolus EOLS Stock Holding History

Y-Intercept (HK)’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-96,068
Closed -$590K – 1669
2025
Q3 		$590K Sell
96,068
-163,419
-63% -$1.27M 0.01% 1205
2025
Q2 		$2.39M Buy
259,487
+222,126
+595% +$2.27M 0.06% 518
2025
Q1 		$449K Buy
+37,361
New +$489K 0.03% 740
2024
Q4 		– Sell
-40,908
Closed -$663K – 1305
2024
Q3 		$663K Buy
40,908
+95
+0.2% +$1.33K 0.04% 637
2024
Q2 		$443K Buy
40,813
+22,554
+124% +$277K 0.02% 871
2024
Q1 		$256K Buy
18,259
+3,848
+27% +$50K 0.02% 1042
2023
Q4 		$152K Buy
+14,411
New +$129K 0.01% 1048

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Y-Intercept (HK)'s EOLS Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Evolus (EOLS) in Q4 2025, closing a stake of 96,068 shares — an estimated $590K sold.

Y-Intercept (HK) first reported a position in EOLS in Q4 2023 and held it in 7 quarters. The position peaked at $2.39M in Q2 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 96,068 Evolus shares in Q4 2025, an estimated $590K.
  • Y-Intercept (HK) first reported a position in Evolus in Q4 2023 and held it in 7 quarters.
  • Y-Intercept (HK)'s Evolus position peaked at $2.39M in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.